Acquired hemophilia A (AHA) is an immune-mediated condition, in which neutralizing autoantibodies (i.e., inhibitors) decrease coagulation factor VIII (FVIII) activity [1]. The gene discussed is F8; the disease is autoimmune hemolytic anemia.